{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:47:05Z","timestamp":1791895625148,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["2083"],"award-info":[{"award-number":["2083"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jgar.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T12:48:09Z","timestamp":1526906889000},"page":"260-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies"],"prefix":"10.1016","volume":"14","author":[{"given":"Azar","family":"Shokri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Abastabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Keighobadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5419-6219","authenticated-orcid":false,"given":"Mahdi","family":"Fakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Hosseini","family":"Teshnizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Makimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rezaei-Matehkolaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.05.007_bib0005","series-title":"Visceral leishmaniosis (kala-azar)","author":"Fakhar","year":"2014"},{"key":"10.1016\/j.jgar.2018.05.007_bib0010","series-title":"Leishmaniasis","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.jgar.2018.05.007_bib0015","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol Biol Int"},{"key":"10.1016\/j.jgar.2018.05.007_bib0020","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1371\/journal.pmed.0030162","article-title":"Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites","volume":"3","author":"Hadighi","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgar.2018.05.007_bib0025","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1016\/j.bmcl.2009.07.081","article-title":"Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents","volume":"19","author":"Agarwal","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jgar.2018.05.007_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23040772","article-title":"In silico discovery of a substituted 6-methoxy-quinalidine with leishmanicidal activity in Leishmania infantum","volume":"23","author":"Stevanovi\u0107","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jgar.2018.05.007_bib0035","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.ejmech.2011.02.021","article-title":"Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents","volume":"46","author":"Marrapu","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jgar.2018.05.007_bib0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4103\/0378-6323.181473","article-title":"Down-regulation of peroxin synthesis by silencing RNA (siRNA): a novel hypothesis for treatment of leishmaniasis","volume":"82","author":"Keighobadi","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jgar.2018.05.007_bib0045","first-page":"49","article-title":"Utility of aptamers for antileishmanial drug targets: a potential hypothesis","volume":"7","author":"Keighobadi","year":"2017","journal-title":"Trop Parasitol"},{"key":"10.1016\/j.jgar.2018.05.007_bib0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.apjtm.2016.09.014","article-title":"Promising antileishmanial effectiveness of doxorubicin and Doxil against Leishmania major: an in vitro assay","volume":"10","author":"Shokri","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.jgar.2018.05.007_bib0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejmech.2017.04.044","article-title":"An overview of azoles targeting sterol 14\u03b1-demethylase for antileishmanial therapy","volume":"135","author":"Emami","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jgar.2018.05.007_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.actatropica.2016.12.027","article-title":"In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major","volume":"167","author":"Shokri","year":"2017","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2018.05.007_bib0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.jgar.2018.05.007_bib0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/mmy\/myw016","article-title":"In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates","volume":"54","author":"Baghi","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2018.05.007_bib0075","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1128\/AAC.01193-16","article-title":"Potent activities of novel imidazoles lanoconazole and luliconazole against a collection of azole-resistant and -susceptible Aspergillus fumigatus strains","volume":"60","author":"Abastabar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.05.007_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/CE.S49629","article-title":"Luliconazole for the treatment of fungal infections: an evidence-based review","volume":"9","author":"Khanna","year":"2014","journal-title":"Core Evid"},{"key":"10.1016\/j.jgar.2018.05.007_bib0085","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/clinids\/2.4.520","article-title":"Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives","volume":"2","author":"Borgers","year":"1980","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jgar.2018.05.007_bib0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2018.05.007_bib0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.exppara.2008.12.004","article-title":"Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species","volume":"121","author":"Poorrajab","year":"2009","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jgar.2018.05.007_bib0100","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.jgar.2018.05.007_bib0105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10822-011-9531-0","article-title":"Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function","volume":"26","author":"Schneider","year":"2012","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.jgar.2018.05.007_bib0110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2013.06.008","article-title":"Synthesis, in vitro antifungal activity and in silico study of 3-(1,2,4-triazol-1-yl)flavanones","volume":"66","author":"Emami","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jgar.2018.05.007_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083247","article-title":"In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis","volume":"8","author":"de Macedo-Silva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2018.05.007_bib0120","first-page":"9","article-title":"Current treatment of leishmaniasis: a review","volume":"1","author":"Monzote","year":"2009","journal-title":"Open Antimicrob Agents J"},{"key":"10.1016\/j.jgar.2018.05.007_bib0125","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1017\/S0031182017000385","article-title":"Safety and efficacy of current alternatives in the topical treatment of cutaneous leishmaniasis: a systematic review","volume":"144","author":"Wolf Nassif","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.jgar.2018.05.007_bib0130","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2018.05.007_bib0135","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00436-013-3274-x","article-title":"Voriconazole suppresses the growth of Leishmania species in vitro","volume":"112","author":"Kulkarni","year":"2013","journal-title":"Parasitol Res"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518300912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518300912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:52:30Z","timestamp":1761990750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518300912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":27,"alternative-id":["S2213716518300912"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.05.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739170778.793580938","asserted-by":"object"}]},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}